Abstract
Gastroesophageal reflux disease (GERD) is a common problem in the outpatient setting affecting 18.1–27.8% of patients in North America. Although medical management is often the primary and mainstay for treatment, invasive techniques with surgical Laparoscopic Nissen Fundoplication or endoscopic Transoral Incisionless Fundoplication (TIF) are being utilized with increasing frequency. Studies have shown excellent short-term results for surgical management with Laparoscopic Fundoplication but with varying outcomes for long-term efficacy. One study found that recurrence of symptoms was not uncommon, and between 3% and 6% of patients will undergo a second procedure. TIF has become increasingly popular in helping to bridge the gap between medical therapy and surgical intervention. However, given the novelty of this procedure, long-term efficacy is unknown.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Similar content being viewed by others
References
Anvari M, Allen C, Marshall J, et al. A randomized controlled trial of laparoscopic Nissen fundoplication versus proton pump inhibitors for the treatment of patients with chronic gastroesophageal reflux disease (GERD): 3-year outcomes. Surg Endosc. 2011;25(8):2547–54.
Castelijns PS, Ponten JE, Poll MC, Bouvy ND, Mulders JF. Quality of life after Nissen fundoplication in patients with gastroesophageal reflux disease: Comparison between long- and short-term follow-up. J Mimim Access Surg. 2018;14(3):213–20.
Lundell L, Attwood S, Ell C, et al. Comparing laparoscopic antireflux surgery with esomeprazole in the management of patients with chronic gastro-oesophageal reflux disease: a 3-year interim analysis of the LOTUS trial. Gut. 2008;57(9):1207–13.
Maret-Ouda J, Wahlin K, El-Serag HB, et al. Association between laparoscopic antireflux surgery and recurrence of gastroesophageal reflux. JAMA. 2017;318:939–46.
Wijnhoven BP, Lally CJ, Kelly JJ, Myers JC, Watson DI. Use of antireflux medication after antireflux surgery. J Gastrointest Surg. 2008;12(3):510–7.
Patti MG, Allaix ME, Fisichella PM. Analysis of the causes of failed antireflux surgery and the principles of treatment: a review. JAMA Surg. 2015;150(6):585–90.
Furnée EJ, Draaisma WA, Broeders IA, Gooszen HG. Surgical reintervention after failed antireflux surgery: a systematic review of the literature. J Gastrointest Surg. 2009;13(8):1539–49.
Witteman BP, Conchillo JM, Rinsma NF, Betzel B, Peeters A, Koek GH, Stassen LP, Bouvy ND. Randomised controlled trial of Transoral incisionless Fundoplication vs proton pump inhibitor for treatment of gastroesophageal reflux disease. Am J Gastroenterol. 2015;110(4):531–42.
Richter JE, Kumar A, Lipka S, Miladinovic B, Velanovich V. Efficacy of Laparoscopic Nissen fundoplication vs transoral incisionless fundoplication or proton pump inhibitors in patients with gastroesophageal reflux disease: a systematic review and network meta-analysis. Gastroenterology. 2018;154(5):1298–1308.e7.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2021 Springer Nature Switzerland AG
About this chapter
Cite this chapter
Ho, S., Welinsky, S. (2021). Recurrence of Symptoms After Surgical Therapies. In: Zundel, N., Melvin, W.S., Patti, M.G., Camacho, D. (eds) Benign Esophageal Disease. Springer, Cham. https://doi.org/10.1007/978-3-030-51489-1_5
Download citation
DOI: https://doi.org/10.1007/978-3-030-51489-1_5
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-51488-4
Online ISBN: 978-3-030-51489-1
eBook Packages: MedicineMedicine (R0)